Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10805
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentrates on the development of drugs. It offers services such as drug prototype development, pre-formulation,formulation development, analytical method development and validation, process optimization, stability testing and storage, and scale-up. Kemwell provides comparator product modification for blinding studies, lab and pilot scale manufacture, clinical packaging and labeling, registration batch manufacture, and technology transfer. The organization offers products in dosage forms of oral, semi-solids, liquids, parenteral and first-in-human formulations. It operates in India, Sweden and the US. Kemwell is headquartered in Bangalore, Karnataka, India.

Kemwell Biopharma Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Acquisition 10
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd – Key Competitors 14
Kemwell Biopharma Pvt Ltd – Key Employees 15
Kemwell Biopharma Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
May 17, 2017: Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd, Key Competitors 14
Kemwell Biopharma Pvt Ltd, Key Employees 15

List of Figures
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Franz Haniel & Cie. GmbH:企業の戦略・SWOT・財務情報
    Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report Summary Franz Haniel & Cie. GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Sun Pharma Advanced Research Company Ltd (SPARC):企業の財務・戦略的SWOT分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Huron Consulting Group Inc:企業のM&A・事業提携・投資動向
    Huron Consulting Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huron Consulting Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Align Technology, Inc.:戦略・SWOT・企業財務分析
    Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary Align Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Achema AB:企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Merit Medical Systems Inc (MMSI):企業の製品パイプライン分析2018
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Nishio Rent All Co.,Ltd. (9699):企業の財務・戦略的SWOT分析
    Nishio Rent All Co.,Ltd. (9699) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Inretail Peru Corp.:企業の戦略的SWOT分析
    Inretail Peru Corp. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services which include dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務分析
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • FBD Holdings Plc (EG7):企業の財務・戦略的SWOT分析
    FBD Holdings Plc (EG7) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Protalix BioTherapeutics Inc (PLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients wi …
  • Grand Haven Board of Light and Power:企業の戦略的SWOT分析
    Grand Haven Board of Light and Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Bando Chemical Industries Ltd (5195):企業の財務・戦略的SWOT分析
    Bando Chemical Industries Ltd (5195) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Perry Ellis International Inc:企業のM&A・事業提携・投資動向
    Perry Ellis International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Perry Ellis International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Globavir Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • HearMeOut Limited (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Limited (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CBRE Group, Inc.:企業の戦略・SWOT・財務分析
    CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary CBRE Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆